Huron Consulting Group Inc. (NASDAQ:HURN) Sees Large Growth in Short Interest

Huron Consulting Group Inc. (NASDAQ:HURN) was the target of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 259,500 shares, a growth of 9.7% from the August 15th total of 236,600 shares. Based on an average daily trading volume, of 141,400 shares, the short-interest ratio is presently 1.8 days. Approximately 1.5% of the company’s shares are short sold.

Insider Buying and Selling at Huron Consulting Group

In other Huron Consulting Group news, Director John Mccartney sold 300 shares of the business’s stock in a transaction that occurred on Monday, July 1st. The stock was sold at an average price of $99.16, for a total transaction of $29,748.00. Following the completion of the transaction, the director now owns 57,688 shares in the company, valued at $5,720,342.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, CEO C. Mark Hussey sold 34,013 shares of the business’s stock in a transaction that occurred on Friday, July 12th. The stock was sold at an average price of $100.69, for a total value of $3,424,768.97. Following the completion of the sale, the chief executive officer now owns 85,081 shares in the company, valued at $8,566,805.89. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director John Mccartney sold 300 shares of the business’s stock in a transaction that occurred on Monday, July 1st. The shares were sold at an average price of $99.16, for a total value of $29,748.00. Following the completion of the sale, the director now owns 57,688 shares of the company’s stock, valued at approximately $5,720,342.08. The disclosure for this sale can be found here. Insiders sold 44,439 shares of company stock worth $4,512,214 over the last 90 days. Company insiders own 2.02% of the company’s stock.

Hedge Funds Weigh In On Huron Consulting Group

Large investors have recently made changes to their positions in the business. Principal Securities Inc. acquired a new position in shares of Huron Consulting Group during the fourth quarter worth $25,000. Covestor Ltd increased its position in shares of Huron Consulting Group by 26,500.0% during the first quarter. Covestor Ltd now owns 266 shares of the business services provider’s stock worth $26,000 after purchasing an additional 265 shares in the last quarter. Ashton Thomas Private Wealth LLC acquired a new position in shares of Huron Consulting Group during the second quarter worth $28,000. Quest Partners LLC acquired a new position in shares of Huron Consulting Group during the fourth quarter worth $97,000. Finally, Assetmark Inc. increased its position in shares of Huron Consulting Group by 40.6% during the fourth quarter. Assetmark Inc. now owns 1,544 shares of the business services provider’s stock worth $159,000 after purchasing an additional 446 shares in the last quarter. 93.90% of the stock is owned by institutional investors and hedge funds.

Huron Consulting Group Stock Down 0.4 %

NASDAQ:HURN traded down $0.47 during trading hours on Wednesday, reaching $106.90. The company’s stock had a trading volume of 89,267 shares, compared to its average volume of 132,600. The company has a market capitalization of $1.92 billion, a P/E ratio of 30.94 and a beta of 0.61. Huron Consulting Group has a 12 month low of $84.26 and a 12 month high of $115.65. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.93 and a current ratio of 1.93. The stock has a 50 day moving average price of $106.61 and a two-hundred day moving average price of $98.11.

Huron Consulting Group (NASDAQ:HURN) last issued its quarterly earnings data on Tuesday, July 30th. The business services provider reported $1.68 EPS for the quarter, topping analysts’ consensus estimates of $1.48 by $0.20. The company had revenue of $371.70 million during the quarter, compared to the consensus estimate of $374.33 million. Huron Consulting Group had a net margin of 5.46% and a return on equity of 20.44%. Huron Consulting Group’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.38 earnings per share. Equities analysts predict that Huron Consulting Group will post 5.95 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on HURN. Benchmark reiterated a “buy” rating and issued a $140.00 price target on shares of Huron Consulting Group in a report on Wednesday, July 31st. Barrington Research reiterated an “outperform” rating and issued a $137.00 price target on shares of Huron Consulting Group in a report on Monday, September 9th. StockNews.com raised shares of Huron Consulting Group from a “sell” rating to a “hold” rating in a research note on Saturday, August 3rd. Finally, Wedbush reissued an “outperform” rating and issued a $110.00 price objective on shares of Huron Consulting Group in a research note on Thursday, May 23rd. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $131.75.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.